Pilosebaceous targeting by isotretenoin-loaded invasomal gel for the treatment of eosinophilic pustular folliculitis: optimization, efficacy and cellular analysis.

Authors:
Mohit Dwivedi
Mohit Dwivedi
a Rajiv Academy for Pharmacy
Vijay Sharma
Vijay Sharma
National University Health System
Singapore
Dr. Kamla Pathak, M.Pharm (Pharmaceutics); Ph.D.
Dr. Kamla Pathak, M.Pharm (Pharmaceutics); Ph.D.
Pharmacy College Saifai, U P RIMS&R, Saifai,
Professor
Etawah, Uttar Pradesh | India

Drug Dev Ind Pharm 2017 Feb 2;43(2):293-304. Epub 2016 Nov 2.

c Department of Pharmaceutics , Pharmacy College Saifai, UPRIMS & R , Saifai, Etawah , Uttar Pradesh , India.

Context: Eosinophilic pustular folliculitis is a secondary symptom associated with HIV infection appears as levels of CD4 lymphocyte cells and T4 lymphocyte cell. Isotretinoin, an analog of vitamin A (retinoid) alters the DNA transcription mechanism and interferes in the process of DNA formation. It also inhibits the eosinophilic chemotactic factors present in sebaceous lipids and in the stratum corneum of patients suffering from this ailment.

Objective: The present research was aimed to formulate isotretenoin-loaded invasomal gel to deliver and target the drug to pilosebaceous follicular unit.

Methods: Nine invasomal formulations (F1-F9) were prepared applying 3 factorial designs and characterized.

Results: Formulation F9 was selected as optimized formulation due to optimum results and highest %CDP of 85.94 ± 1.86% in 8 h. Transmission electron microscopy (TEM) suggested uniformity in vesicles shape and size in F9 and developed as invasomal gel (IG).

Limitations: Clinical phase-I, phase-II, and phase-III studies will be required before using on human patients.

Conclusion: Confocal laser scanning microscopy (CLSM) validates that IG successfully reaches the pilosebaceous follicular unit and further studied on cell line (SZ-95) exhibited IC50 of ≤8 (25 μM of isotretenoin). Cell cycle analysis confirmed IG arrested the cell growth up to 82% with insignificant difference to pure isotretenion.

Download full-text PDF

Source
http://dx.doi.org/10.1080/03639045.2016.1239628DOI Listing
February 2017
30 Reads
2 Citations
2.010 Impact Factor

Publication Analysis

Top Keywords

invasomal gel
12
pustular folliculitis
8
eosinophilic pustular
8
pilosebaceous follicular
8
isotretenoin-loaded invasomal
8
deliver target
4
gel deliver
4
reaches pilosebaceous
4
target drug
4
drug pilosebaceous
4
validates reaches
4
unitmethods invasomal
4
prepared applying
4
microscopy clsm
4
applying factorial
4
f1-f9 prepared
4
formulations f1-f9
4
follicular unit
4
invasomal formulations
4
clsm validates
4

References

(Supplied by CrossRef)
Article in Acta Derm Venereol
Ofuji S et al.
Acta Derm Venereol 1970
Article in Cutis
Hiromi T et al.
Cutis 2004
Article in G Ital Dermatol Venereol
Boone SL et al.
G Ital Dermatol Venereol 2008
Article in Hong Kong J Derm Venereol
Au AWM et al.
Hong Kong J Derm Venereol 2008

Similar Publications